本文選題：喉癌 + 生存質(zhì)量　； 參考：《中國老年學(xué)雜志》2016年08期

【摘要】：正喉癌是發(fā)生于喉部的惡性腫瘤,占呼吸道惡性腫瘤的65%~70%〔1〕,是僅次于肺癌的呼吸道第2位高發(fā)癌,位于耳鼻喉科惡性腫瘤的第3位〔2,3〕。近40年來喉癌的發(fā)病率有增多的趨勢,經(jīng)全國腫瘤登記中心審核、整理和統(tǒng)計分析,2003~2007年我國喉癌粗發(fā)病率2.04/10萬〔4〕。喉癌的發(fā)病年齡以50~70歲多見。目前喉癌的治療手段以手術(shù)為主,輔以放化療,其早期治療后5年生存率可達79%〔5〕,晚期5年生存率為
[Abstract]:Positive laryngeal carcinoma is a malignant tumor occurring in larynx, which accounts for 6570% of respiratory malignant tumor. It is the second most common cancer in respiratory tract after lung cancer, and the third most common malignant tumor in the department of otolaryngology. The incidence of laryngeal cancer has been increasing in the past 40 years. It has been reviewed by the National Cancer Registration Center and analyzed statistically. From 2003 to 2007, the crude incidence of laryngeal cancer in China was 2.04-100000. The onset age of laryngeal cancer is more than 50 ~ 70 years old. At present, the treatment of laryngeal cancer is mainly surgery, supplemented by radiotherapy and chemotherapy. The 5-year survival rate of laryngeal carcinoma after early treatment can reach 79%, and the late 5-year survival rate is as follows:
【作者單位】： 蚌埠醫(yī)學(xué)院護理學(xué)系;蚌埠醫(yī)學(xué)院第一附屬醫(yī)院耳鼻喉-頭頸外科;
【分類號】：R473.73

【相似文獻】

相關(guān)期刊論文 前10條

1 范紅萍,邱永梅,田軍;提高原發(fā)性硬化性膽管炎患者生存質(zhì)量的護理[J];齊齊哈爾醫(yī)學(xué)院學(xué)報;2003年10期

2 吳建能,李曉春,劉愛瑛;健康教育在提高2型糖尿病患者生存質(zhì)量中的作用[J];齊齊哈爾醫(yī)學(xué)院學(xué)報;2004年11期

3 王秀玲;;知情護理和保密護理對肝癌患者生存質(zhì)量的對比分析[J];齊魯護理雜志;2006年19期

4 張t，

本文編號：1984149